Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Prostate Carcinoma
100%
Insulin Resistance
100%
Hyperglycemia
100%
Androgen Deprivation Therapy
100%
Therapy Groups
61%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
19%
Fasting Blood Glucose
14%
Testosterone
9%
Free Testosterone
9%
Insulin Level
9%
Metabolic Profile
9%
Age-matched
9%
Radiotherapy
4%
United States
4%
Cardiovascular Mortality
4%
Malignancy
4%
Metabolic Alterations
4%
Glucose-insulin System
4%
Total Testosterone
4%
Metastatic Prostate Carcinoma
4%
Direct Results
4%
Hypogonadism
4%
3-group
4%
Prostatectomy
4%
Leptin Levels
4%
Serum Testosterone
4%
Fasting Insulin
4%
Total Testosterone Levels
4%
Leptin
4%
High BMI
4%
Glucose Level
4%
Hypogonadal Men
4%
Male Hypogonadism
4%
University-based Research
4%
Androgen Deprivation
4%
Cardiovascular Risk Factors
4%
Diabetes History
4%
Diabetes Mellitus
4%
2-deoxyglucose Resistance
4%
Medicine and Dentistry
Prostate Carcinoma
100%
Hyperglycemia
100%
Insulin Resistance
100%
Androgen Deprivation Therapy
100%
Group Therapy
61%
Homeostatic Model Assessment
19%
Glucose
19%
Body Mass Index
14%
Insulin
14%
Hypogonadism
9%
Leptin
9%
Cardiovascular Disease
4%
Diabetes Mellitus
4%
Cross Sectional Study
4%
Prostatectomy
4%
Cancer
4%
Cardiovascular Mortality
4%
Androgen
4%
Testosterone
4%
Radiation Therapy
4%
Nursing and Health Professions
Hyperglycemia
100%
Insulin Resistance
100%
Prostate Carcinoma
100%
Androgen Deprivation Therapy
100%
Homeostasis Model Assessment
19%
Glucose Level
9%
Insulin Level
9%
Leptin
9%
Hypogonadism
9%
Glucose
9%
Diabetes Mellitus
4%
Cardiovascular Disease
4%
Androgen
4%
Cardiovascular Mortality
4%
Prostatectomy
4%
Testosterone
4%
Radiotherapy
4%
Cross-Sectional Study
4%
Insulin
4%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen
100%
Insulin Resistance
100%
Hyperglycemia
100%
Prostate Carcinoma
100%
Glucose
18%
Insulin
13%
Hypogonadism
9%
Leptin
9%
Diabetes Mellitus
4%
Cardiovascular Mortality
4%
Testosterone
4%
Cardiovascular Disease
4%
Cross-Sectional Study
4%